Ohio State is in the process of revising websites and program materials to accurately reflect compliance with the law. While this work occurs, language referencing protected class status or other activities prohibited by Ohio Senate Bill 1 may still appear in some places. However, all programs and activities are being administered in compliance with federal and state law.

Ken Oestreich

Ken Oestreich

Ken Oestreich

Associate Professor, Microbial Infection & Immunity

oestreich.20@osu.edu

(614)685-3549

798 Biomedical Research Tower
460 W. 12th Ave.
Columbus, OH
43210

Google Map

Areas of Expertise

  • Gene Expression
  • Cancer Biology
  • Molecular Medicine
  • Bioinformatics

Education

  • PhD: Vanderbilt University

Effective immune responses to eliminate both pathogenic infection and tumorigenic cells require the differentiation and function of immune cell populations including CD4+ T helper and CD8+ cytotoxic T cells.  During such responses, CD4+ and CD8+ T cells proliferate and form armies of effector T cells that coordinate the immune response and eliminate both pathogen-infected and tumor cells, respectively. As the threat is eliminated, the number of effector T cells is reduced to avoid potential autoimmunity. During this phase, long-lived memory T cells survive to respond more quickly and robustly to repeated encounters with the same pathogenic insult. This effector-to-memory transition is required for the generation of both natural and vaccine-induced long-term immunity.

Our laboratory uses state-of-the-art experimental approaches to elucidate the role of environmental signals and downstream transcription factor networks in regulating both effector and memory T cell differentiation decisions. Ultimately, the overarching goal of our research is to leverage these findings for the development of novel immunotherapeutic strategies to treat human disease.

People Filters: